WPRIM Management System> DCMS> Blood Research> 2020> 55> 1

Volume: 55 Issue: 1

1. Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how? Page:67—68
2. Response to the letter by Langabeer on “Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria” Page:68—68
3. Helicobacter pylori testing in a population of Korean patients with pernicious anemia Page:69—69
4. Clinical significance of myeloproliferative neoplasms with JAK2V617F mutations and major BCR-ABL1 translocations: a literature review with case presentation Page:62—65
5. Daratumumab in dialysis-dependent multiple myeloma Page:65—67
6. Bibliometric analysis of studies about acute myeloid leukemia conducted globally from 1999 to 2018 Page:1—9
7. Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience Page:57—61
8. Characteristics of DNMT3A mutations in acute myeloid leukemia Page:17—26
9. A general view of CD33⁺ leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy Page:10—16
10. Human platelet lysate efficiency, stability, and optimal heparin concentration required in culture of mammalian cells Page:35—43
11. Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome Page:27—34
12. Thromboprophylaxis after bariatric surgery Page:44—48
13. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases Page:49—56